Digital PCR Market

The report "Digital PCR Market Size, Growth by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to 2025" is projected to reach USD 7.6 billion by 2025, at a CAGR of 9.0%.

Browse 253 market data Tables and 41 Figures spread through 316 Pages and in-depth TOC on "Digital PCR Market - Global Forecast to 2025"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market-174151204.html

qPCR reagents and consumables accounted for the largest share of Digital PCR Market

Based on products & services, the qPCR market is categorized into reagents and consumables, instruments and software & services. The qPCR reagents and consumables segment is expected to command the largest share of the qPCR products & services market in 2020. This segment includes qPCR reagents (such as supermixes, enzymes, and specific detection agents) and consumables (such as reaction tubes, needles, and vials) required during a typical qPCR analysis procedure. The sale of qPCR reagents through various approaches by prominent players (such as bundled sales of qPCR reagents for 3-5 years along with the purchase of qPCR instruments; long-term sales contracts for qPCR reagents upon device upgradation; and bundled sales of related consumables on the long-term purchase of qPCR reagents) is also a major factor driving the demand and uptake of qPCR reagents & consumables in major markets such as Europe, the US, Japan, China, and India.

Clinical application segment accounted for the largest share of Digital PCR Market

Based on application, the qPCR market is categorized into clinical applications (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics and Other Clinical Applications), research applications and forensic applications. The clinical applications segment is estimated to dominate the qPCR applications market in 2020. qPCR analysis has transformed significantly from a conventional DNA quantification technique into an advanced diagnostic technique used in several diagnostic applications, such as prenatal testing to identify inborn genetic defects, disease diagnosis such as early cancer detection, pathogen detection in infections (such as anthrax, malaria, herpes, hepatitis, HIV, and tuberculosis), and the identification of blood-borne diseases during a blood transfusion.

The hospitals and diagnostic centers is the largest and fastest gowing end user segment of the qPCR market

Based on end users, the qPCR market is segmented into research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations (CROs), and forensic laboratories. In 2019, the hospitals and diagnostic centers segment accounted for the largest share of the market. The hospitals and diagnostic centers segment includes in-house diagnostic and clinical research centers at hospitals, intendant diagnostic & pathology centers, and reference laboratories (that work for small hospitals, independent physicians, and community clinics). These end-users use qPCR analysis in the diagnosis of target diseases and disorders (including cancer, HIV-AIDS, genetic disorders, infectious diseases, and chronic diseases, among others).

North America accounted for the largest share of the dPCR and qPCR market

North America accounted for the largest share of the digital PCR market, followed by Europe in 2019. North America is a mature market with a high penetration of qPCR and dPCR technologies among key end users (including hospitals, diagnostic centers, research laboratories, pharmaceutical and biotechnology companies, and forensic laboratories), robust genomics research infrastructure, and strong market presence of genomic product manufacturers.

The prominent players operating in the digital PCR market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland).

Don’t miss out on business opportunities in Digital PCR (dPCR) and Real-time PCR (qPCR) Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]